CORPUS CHRISTI, Texas--(BUSINESS WIRE)--CSMG Technologies, Inc., (OTCBB: CTUM), a technology management company focused on commercializing human live tissue bonding devices and renewable energy landfill gas production systems, announced that its Live Tissue Connect (“LTC”) technology subsidiary has completed its duct and vessel sealer prototype. This is the first specific procedure device of some 13 specific procedure devices LTC has identified from over 80 procedures performed by the technology’s universal device used in Ukraine. LTC will begin the second prototype specific procedure device for end-to-end, end-to-side and side-to-side anastomosis (reconnection) of intestines which should be completed in about four months.
